Zobrazeno 1 - 10
of 238
pro vyhledávání: '"He, Weili"'
Autor:
Chen, Jie, Di, Junrui, Daizadeh, Nadia, Lu, Ying, Wang, Hongwei, Shen, Yuan-Li, Kirk, Jennifer, Rockhold, Frank W., Pang, Herbert, Zhao, Jing, He, Weili, Potter, Andrew, Lee, Hana
There has been a growing trend that activities relating to clinical trials take place at locations other than traditional trial sites (hence decentralized clinical trials or DCTs), some of which are at settings of real-world clinical practice. Althou
Externí odkaz:
http://arxiv.org/abs/2410.06591
Autor:
Chen, Jie, Gruber, Susan, Lee, Hana, Chu, Haitao, Lee, Shiowjen, Tian, Haijun, Wang, Yan, He, Weili, Jemielita, Thomas, Song, Yang, Tamura, Roy, Tian, Lu, Zhao, Yihua, Chen, Yong, van der Laan, Mark, Nie, Lei
Real-world data (RWD) and real-world evidence (RWE) have been increasingly used in medical product development and regulatory decision-making, especially for rare diseases. After outlining the challenges and possible strategies to address the challen
Externí odkaz:
http://arxiv.org/abs/2410.06586
Autor:
Chen, Jie, Nie, Lei, Lee, Shiowjen, Chu, Haitao, Tian, Haijun, Wang, Yan, He, Weili, Jemielita, Thomas, Gruber, Susan, Song, Yang, Tamura, Roy, Tian, Lu, Zhao, Yihua, Chen, Yong, van der Laan, Mark, Lee, Hana
Developing drugs for rare diseases presents unique challenges from a statistical perspective. These challenges may include slowly progressive diseases with unmet medical needs, poorly understood natural history, small population size, diversified phe
Externí odkaz:
http://arxiv.org/abs/2410.06585
Autor:
Chen, Jie, Scharfstein, Daniel, Wang, Hongwei, Yu, Binbing, Song, Yang, He, Weili, Scott, John, Lin, Xiwu, Lee, Hana
A Real-World Evidence (RWE) Scientific Working Group (SWG) of the American Statistical Association Biopharmaceutical Section (ASA BIOP) has been reviewing statistical considerations for the generation of RWE to support regulatory decision-making. As
Externí odkaz:
http://arxiv.org/abs/2307.00190
The stochastic nature of public transport systems leads to headway variability and bus bunching, causing both operator and passenger cost to increase significantly. Traditional strategies to counter bus bunching, including bus-holding, stop-skipping,
Externí odkaz:
http://arxiv.org/abs/2202.06039
In oncology clinical trials, characterizing the long-term overall survival (OS) benefit for an experimental drug or treatment regimen (experimental group) is often unobservable if some patients in the control group switch to drugs in the experimental
Externí odkaz:
http://arxiv.org/abs/1908.00654
Publikováno v:
In Engineering Structures 15 April 2023 281
Autor:
Zheng, Jiehuang, He, Weili, Chen, Yan, Li, Lihong, Liang, Qinghe, Dai, Wenqi, Li, Ruopeng, Chen, Fengsheng, Chen, Ziye, Tan, Yanhui, Li, Xiaojuan
Publikováno v:
In Journal of Advanced Research March 2024
Publikováno v:
In Transportation Research Part C January 2023 146